Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation
Renate B. Schnabel(Universität Hamburg), Paulus Kirchhof(Universität Hamburg), Markus Lucerna(Daiichi Sankyo (Germany)), Stefan Blankenberg(Universität Hamburg), Harald Darius(Vivantes Klinikum), Francisco Ojeda(Universidad Complutense de Madrid), Raffaele De Caterina(University of Pisa), Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Nargiz Rzayeva(Universität Hamburg), Ladislav Pecen(Charles University)
Cited by 189
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k